Award Banner
Award Banner

Taconic Biosciences Launches New Immuno-oncology Mouse Model

Taconic Biosciences Launches New Immuno-oncology Mouse Model Expands and Broadens Taconic Biosciences’ Immuno-oncology Portfolio Application GlobeNewswire January 31, 2020

RENSSELAER, N.Y., Jan. 31, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its premier immuno-oncology portfolio with the launch of the new B2m-NOG mouse model.

Immuno-oncology leverages the body’s immune system to fight cancer, increasing the ability to target the disease.  Animal models used in this therapeutic development include special mice, which model human immune system function.  Taconic’s immuno-oncology portfolio is built on the CIEA NOG mouse®, a severely immunodeficient mouse with diverse applications based on its improved ability to engraft human cells and tissues.  B2m-NOG is an important addition to this portfolio because it significantly extends the study window after human peripheral blood mononuclear (PBMC) cell engraftment, providing more time to assess reactions to target drugs.  The extended study window dramatically expands immuno-oncology study types that can be run using the B2m-NOG model compared with more expensive and time-consuming options, such as hematopoietic stem cell-engrafted models. Taconic also offers B2m-NOG mice pre-engrafted with human PBMCs.

“Taconic is in a unique position to impact immuno-oncology research,” commented Dr. Michael Seiler, vice president of commercial products at Taconic. “Combining the extended study windows possible with B2m-NOG with Taconic’s expert consultation from PhD-level field application scientists enables our customers to quickly integrate this new tool into their experimental workflow.”

To learn more about Taconic Biosciences' humanized model portfolio, please contact Taconic at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact:

Kelly Owen Grover

Director of Marketing Communications

(518) 697-3824

Primary Logo

This website is best viewed using the latest versions of web browsers.